Julian L Stowers

Title: The Innovations of Julian L. Stowers

Introduction

Julian L. Stowers is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the delivery of raloxifene, a medication used primarily for the treatment of osteoporosis.

Latest Patents

Stowers holds 4 patents that showcase his innovative work. His latest patents include a solid orally administerable raloxifene hydrochloride pharmaceutical. This invention provides orally administerable pharmaceutical formulations comprising raloxifene, its ethers or esters, or a pharmaceutically-acceptable salt thereof, in combination with a hydrophilic carrier composition. Another patent focuses on solid orally administerable formulations that include raloxifene hydrochloride, a surfactant being sorbitan fatty acid ester or a polyoxyethylene sorbitan fatty acid ester, polyvinylpyrrolidone, and a water-soluble diluent which is polyol or sugar.

Career Highlights

Stowers has built a successful career at Eli Lilly and Company, where he has been instrumental in advancing pharmaceutical formulations. His work has contributed to the development of effective treatments that improve patient outcomes.

Collaborations

Throughout his career, Stowers has collaborated with esteemed colleagues, including Lowell L. Gibson and Kerry John Hartauer. These partnerships have fostered innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Julian L. Stowers exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations have significantly impacted the field, making him a noteworthy inventor in the realm of pharmaceuticals.